Petoro AS:企業の戦略的SWOT分析

◆英語タイトル:Petoro AS - Strategic SWOT Analysis Review
◆商品コード:DATA904C0575
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Petoro AS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state’s direct involvement in petroleum activities. Petoro has three major responsibilities assigned by the state government, namely, to manage the government’s holdings in the joint venture, to monitor the state’s direct financial interest in upstream assets, and to manage the government’s financial investments. The company is owned by the government of Norway. Petoro is headquartered in Stavanger, Norway.

Petoro AS Key Recent Developments

Jul 18,2018: Wellesley receives drilling permit for well 35/11-21 S in PL 248 I
Jul 05,2018: Norway Approves PDO For Snorre Expansion Project
Jul 05,2018: Equinor’s Troll Phase III plan to boost European gas exports
Jul 03,2018: Equinor And Partners Submit Plan For Further Development Of Troll Field
Jul 03,2018: Norwegian Energy Producer To Expand North Sea Field Output

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Petoro AS – Key Facts 5
Petoro AS – Key Employees 6
Petoro AS – Key Employee Biographies 7
Petoro AS – Major Products and Services 8
Petoro AS – History 9
Petoro AS – Company Statement 11
Petoro AS – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Affiliate 13
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
Petoro AS – Business Description 15
Petoro AS – SWOT Analysis 16
SWOT Analysis – Overview 16
Petoro AS – Strengths 16
Petoro AS – Weaknesses 17
Petoro AS – Opportunities 18
Petoro AS – Threats 19
Petoro AS – Key Competitors 20
Section 3 – Company’s Oil & Gas Financial Deals and Alliances 21
Petoro AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 21
Petoro AS, Oil & Gas, Deals By Type, 2012 to YTD 2018 22
Petoro AS, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
Jul 05, 2018: Equinor’s Troll Phase III plan to boost European gas exports 24
Jul 05, 2018: Equinor’s Troll Phase III plan to boost European gas exports 25
Jun 27, 2018: NPD: Drilling Permit For Wells 6608/10-18, 6608/10-18 A And 6608/10-18 B In Production Licence 128 D 26
Jun 22, 2018: 24th Licensing Round Award To Idemitsu 27
Jun 19, 2018: Wintershall Awarded License In 24th Licensing Round 28
Jun 12, 2018: Equinor: Johan Castberg PDO Approved 29
May 31, 2018: Equinor: Johan Sverdrup Drilling Topside Sailaway 30
May 18, 2018: Neptune Energy Awards EPCIC Contract For Nova Tie-back To Gjoa 32
May 09, 2018: Petoro Announces Strongest Start Of Year Since 2014 33
May 03, 2018: Statoil: Mobilising Offshore Organisation For Johan Sverdrup Field 34
Section 5 – Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 36

List of Tables
Petoro AS, Key Facts 5
Petoro AS, Key Employees 6
Petoro AS, Key Employee Biographies 7
Petoro AS, Major Products and Services 8
Petoro AS, History 9
Petoro AS, Subsidiaries 13
Petoro AS, Affiliate 13
Petoro AS, Joint Venture 13
Petoro AS, Key Competitors 20
Petoro AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 21
Petoro AS, Oil & Gas, Deals By Type, 2012 to YTD 2018 22
Petoro AS, Recent Deals Summary 23
Units 35

List of Figures
Petoro AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 21
Petoro AS, Oil & Gas, Deals by Type, 2012 to YTD 2018 22

★海外企業調査レポート[Petoro AS:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xintela AB (XINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • Tokyo Gas Co Ltd (9531):電力:M&Aディール及び事業提携情報
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • Biscayne Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biscayne Pharmaceuticals Inc (Biscayne) is a clinical stage biotechnology company that conducts research and development services. The company conducts research and development of therapies based on growth hormone-releasing hormone analogs. Its technology concentrates on a platform of synthe …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Skandinaviska Enskilda Banken AB:企業の戦略・SWOT・財務分析
    Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report Summary Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • INRange Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets medication delivery systems. The company offers EMMA, a remote medication management system that provides individual unit dose control of medication dispensing, which is managed through a web-based scheduling …
  • Vietnam Electricity:企業の戦略的SWOT分析
    Vietnam Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • AutoNation, Inc. (AN):企業の財務・戦略的SWOT分析
    AutoNation, Inc. (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NextEra Energy Resources LLC-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • Metro AG:戦略・SWOT・企業財務分析
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ceapro Inc (CZO)-製薬・医療分野:企業M&A・提携分析
    Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and ani …
  • MiMedx Group Inc (MDXG):企業の製品パイプライン分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Zahroof Valves Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Zahroof Valves Inc (Zahroof Valves) is a manufacturer and supplier of industrial valves. The company offers straightflo valve (SF) for use in reciprocating gas compressors. Its valves are used in gas production, gas gathering, gas transmission, gas storage and gas distribution applications. …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • Hannover Ruck SE:企業の戦略・SWOT・財務分析
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Silverleaf Resorts, Inc.:企業の戦略・SWOT・財務情報
    Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Take-Two Interactive Software, Inc.:企業の戦略・SWOT・財務分析
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Koninklijke Philips N.V. (PHIA)-エネルギー分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆